Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Quantumzyme (QTZM) Operating Expenses (2016 - 2026)

Quantumzyme (QTZM) has 6 years of Operating Expenses data on record, last reported at $39196.0 in Q4 2025.

  • For Q4 2025, Operating Expenses fell 35.67% year-over-year to $39196.0; the TTM value through Oct 2025 reached $100130.0, up 37.04%, while the annual FY2025 figure was $180537.0, 10.36% up from the prior year.
  • Operating Expenses reached $39196.0 in Q4 2025 per QTZM's latest filing, down from $60934.0 in the prior quarter.
  • Across five years, Operating Expenses topped out at $60934.0 in Q4 2024 and bottomed at $39196.0 in Q4 2025.